Latest | F'cast | |
---|---|---|
Div Yield | 0.9% | 0.0% |
Div Cover | n/a | 2.6 |
Op Mrgn | n/a | 27.4% |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | 39.6 | 10.1 |
PEG | n/a | 3.4 |
Pr/Revenue | 9.6 | 2.1 |
Pr/Book | 5.3 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | 330.8% |
PBT | 7.7% | 541.3% |
EPS | n/a | 3.0% |
DPS | n/a | 303.4% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 33,754.00 | 6,221.00 | 123.90p | 17.9 | 4.5 | +4% | 80.00p | 3.6% |
31-Dec-20 | 34,099.00 | 6,968.00 | 115.90p | 14.5 | n/a | -6% | 80.00p | 4.8% |
31-Dec-21 | 24,696.00 | 3,599.00 | 90.56p | 22.2 | n/a | -22% | 80.00p | 4.0% |
31-Dec-22 | 29,324.00 | 5,628.00 | 139.70p | 10.3 | 0.2 | +54% | 44.00p | 3.1% |
31-Dec-23 | 30,328.00 | 6,064.00 | 155.10p | 9.4 | 0.9 | +11% | 42.00p | 2.9% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 31,722.79 | 8,690.03 | 159.70p | 10.0 | 3.4 | +3% | 60.50p | 0.0% |
31-Dec-25 | 33,734.70 | 9,752.38 | 176.92p | 9.1 | 0.8 | +11% | 64.40p | 0.0% |
31-Dec-26 | 35,484.71 | 10,821.53 | 194.79p | 8.2 | 0.8 | +10% | 68.87p | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Director/PDMR Shareholding | 12-Jun-2024 | 15:30 | RNS |
Statement: Zantac (ranitidine) litigation | 11-Jun-2024 | 07:00 | RNS |
Statement: Zantac (ranitidine) litigation | 10-Jun-2024 | 18:27 | RNS |
GSK looks a bargain buy despite legal problems | 13-Jun-2024 | Times |
GSK to begin appeal over Zantac setback | 11-Jun-2024 | Times |
GlaxoSmithKline scraps sale of old drugs | 05-Dec-2014 | Telegraph |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
11-Jun-24 | Transfer From | Julie Brown | 0.000p | 8 | £0.00 |
11-Jun-24 | Buy | Julie Brown | 1,623.24p | 8 | £129.86 |
11-Jun-24 | Transfer From | Emma Walmsley | 0.000p | 8 | £0.00 |
Currency | UK Pounds |
Share Price | 1,604.50p |
Change Today | -5.50p |
% Change | -0.34 % |
52 Week High | 1,812.50p |
52 Week Low | 1,316.00p |
Volume | 4,229,876 |
Shares Issued | 4,144.96m |
Market Cap | £66,506m |
RiskGrade | 129 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 4 |
Neutral | 10 |
Sell | 2 |
Strong Sell | 0 |
Total | 24 |
Latest | Previous | |
---|---|---|
Q1 | Q4 | |
Ex-Div | 16-May-24 | 22-Feb-24 |
Paid | 11-Jul-24 | 11-Apr-24 |
Amount | 15.00p | 16.00p |
Time | Volume / Share Price |
16:35 | 35,372 @ 1,604.50p |
16:35 | 2,548 @ 1,604.50p |
16:35 | 2,217,428 @ 1,604.50p |
16:35 | 2,192 @ 1,604.50p |
16:35 | 1,750 @ 1,604.50p |
You are here: research